We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Saliva-Based Test Detects Biochemical Signs of Sleep Loss

By LabMedica International staff writers
Posted on 04 Jun 2026

Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. More...

Clinicians currently lack an objective biochemical test to determine when someone is dangerously sleep deprived, complicating triage and enforcement in high-risk settings. Drowsy driving alone contributes to tens of thousands of crashes annually in the United States, underscoring the need for rapid, noninvasive assessment tools. A new study shows that specific patterns of saliva metabolites can distinguish well-rested from sleep-deprived individuals.

Researchers at the University of Zurich developed a saliva-based metabolomic approach that profiles oral fluid to create a “sleepiness fingerprint.” The team analyzed metabolite compositions in samples collected before and after controlled sleep conditions, then trained a predictive model to classify acute sleep loss. Noninvasive by design, the strategy is framed for use in contexts ranging from roadside checks to clinical environments.

Researchers enrolled 20 healthy young adult males who typically slept seven to nine hours nightly. Each participant completed three scenarios in randomized order one week apart: one night without sleep (deprivation), four nights restricted by two hours below usual sleep (restriction), and approximately eight hours per night (well rested). Saliva was collected before and after each scenario for metabolomic analysis.

Statistical analyses identified 10 molecular differences between the well-rested and sleep-deprived states, whereas the restricted-sleep state did not differ significantly from rested. A predictive model built from the varying salivary metabolites correctly identified samples from sleep-deprived individuals 94% of the time. Some errors were likely related to individual metabolic processes; notably, after 24 hours awake, a subset of participants did not return to a fully rested metabolic profile after eight hours of sleep.

The findings, published in the American Chemical Society's Journal of Proteome Research on May 6, 2026, support a metabolite-based “sleepiness fingerprint” alongside a predictive model that discriminates acute deprivation. The team is initiating a large-scale international assessment, expanding tests to more than 1,000 samples drawn from shift workers, women, and frequent drivers. 

“Until now, sleep deprivation has been impossible to measure biochemically—and yet it is one of the greatest burdens of our time. This study introduces the first direct biomarkers of sleep loss in saliva under real-world conditions, marking a milestone in forensic investigations,” said Thomas Kraemer, corresponding author of the study.

Related Links
University of Zurich 
American Chemical Society


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.